Leukemia cells lacking PTEN reveal a metabolic weakness that approved drugs can exploit
Loss of PTEN makes T-cell acute lymphoblastic leukemia cells dependent on the guanylate-synthesis enzyme IMPDH, allowing clinically approved IMPDH inhibitors ...
Loss of PTEN makes T-cell acute lymphoblastic leukemia cells dependent on the guanylate-synthesis enzyme IMPDH, allowing clinically approved IMPDH inhibitors ...
In a groundbreaking study poised to reshape our understanding of how cells preserve genomic integrity during DNA replication, researchers have ...
In a groundbreaking study that challenges long-held assumptions in oncology, researchers at the Korea Advanced Institute of Science and Technology ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.